ClinConnect ClinConnect Logo
Search / Trial NCT05949983

Health Economic Evaluation of an Adapted Physical Activity Program for Women With Breast Cancer

Launched by UNIVERSITY HOSPITAL, TOULOUSE · Jul 17, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Physical Activity Exercise Exercise Therapy Breast Neoplasms Medical Costs Healthcare Costs

ClinConnect Summary

This clinical trial is studying the effects of a special physical activity program designed for women who are currently being treated for breast cancer. The program is called Adapted Physical Activity (APA) and has been recognized as a helpful non-drug therapy. The researchers believe that participating in this program may improve the quality of life for women undergoing treatment and could also lower health care costs. They will compare this standardized APA program to regular recommendations for physical activity to see which is more effective during cancer treatment.

To participate in this trial, women must have any type of breast cancer and be receiving treatment, which could include surgery, chemotherapy, radiation, or hormone therapy. However, there are some health conditions that would prevent someone from joining, such as severe heart or lung problems, recent surgery, or extreme fatigue. The trial is not yet recruiting participants, but women who meet the eligibility criteria can expect to be part of a study that aims to explore how physical activity can support their health during treatment.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • women with breast cancer
  • any type of breast cancer, all grades, all stages
  • during treatment: surgery +/- chemotherapy +/- radiotherapy +/- hormone therapy
  • Exclusion Criteria:
  • World Health Organization (WHO) 4
  • Unstable angina
  • Uncontrolled Atrial fibrillation
  • Uncontrolled high blood pressure
  • Recent myocardial infarction or myocarditis or pericarditis or thromboembolic disease (less than 3 weeks)
  • Aortic stenosis or valve disease to operate
  • Cardiac or respiratory failure, with dyspnea at rest
  • Symptomatic anemia, thrombocytopenia
  • Lytic or painful bone metastases, Severe osteoporosis
  • Severe infectious syndrome,
  • Surgery in the last 3 weeks
  • Extreme fatigue, sharp pain, dizziness, disturbance of consciousness, severe undernutrition
  • Contraindication to the practice of an adapted physical activity programme
  • Currently involved or exclusion period of a interventional study or adapted Physical Activity program
  • Patient with protective measures (guardianship, curators, and deprivation of liberty).
  • Pregnancy or breastfeeding
  • Patient with severe functional limitations

About University Hospital, Toulouse

The University Hospital of Toulouse is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific inquiry with comprehensive clinical services. Its multidisciplinary team of healthcare professionals collaborates with renowned researchers to facilitate pioneering studies across various medical fields, aiming to enhance treatment options and improve patient outcomes. As a prominent institution in the region, the University Hospital of Toulouse is committed to fostering an environment of excellence in both education and research within the healthcare community.

Locations

Toulouse, , France

Patients applied

0 patients applied

Trial Officials

Marie-Eve Rougé-Bugat, MD

Principal Investigator

University Toulouse

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported